American Heart Journal Plus: Cardiology Research and Practice
Scope & Guideline
Connecting Researchers and Practitioners in Cardiology
Introduction
Aims and Scopes
- Cardiovascular Disease Mechanisms and Treatment:
Research articles often explore the underlying mechanisms of cardiovascular diseases, including heart failure, arrhythmias, and coronary artery disease, alongside novel therapeutic approaches such as pharmacotherapy and interventional procedures. - Health Disparities and Social Determinants of Health:
A significant focus is placed on understanding and addressing health disparities, particularly within marginalized populations, emphasizing how social determinants influence cardiovascular outcomes. - Innovative Diagnostic and Therapeutic Technologies:
The journal highlights advancements in diagnostic technologies, such as imaging techniques and biomarker assessments, as well as new therapeutic modalities including catheter-based interventions and pharmacological treatments. - Cardio-Oncology and Cardiovascular Toxicity:
There is a growing emphasis on the intersection of cardiology and oncology, exploring the cardiovascular implications of cancer treatments and the management of patients with coexisting cardiovascular conditions. - Gender and Racial Disparities in Cardiovascular Health:
Research aims to elucidate the differences in cardiovascular health outcomes across genders and races, advocating for tailored prevention and treatment strategies.
Trending and Emerging
- Impact of COVID-19 on Cardiovascular Health:
Recent publications increasingly explore the cardiovascular implications of COVID-19, including its effects on patients with pre-existing conditions and the long-term outcomes post-infection. - Telemedicine and Remote Patient Monitoring:
With the rise of telehealth, there is growing research on the efficacy and outcomes of remote monitoring technologies for managing cardiovascular diseases, particularly in the context of the COVID-19 pandemic. - Interdisciplinary Approaches in Cardio-Oncology:
Emerging studies focus on the intersection of cardiology and oncology, highlighting how cancer treatments affect cardiovascular health and the importance of integrated care models. - Personalized Medicine and Pharmacogenomics:
There is an increasing emphasis on personalized treatment strategies based on genetic and phenotypic variations among patients, particularly in the context of pharmacotherapy for cardiovascular diseases. - Environmental and Lifestyle Factors in Cardiovascular Health:
Research is trending towards understanding the impact of environmental factors, such as pollution and lifestyle choices, on cardiovascular health, highlighting the role of public health initiatives.
Declining or Waning
- Traditional Risk Factor Studies:
There is a noticeable decrease in studies focusing solely on traditional cardiovascular risk factors (e.g., hypertension, hyperlipidemia) without incorporating newer insights into pathophysiological mechanisms or social determinants. - Basic Science Research:
The journal has seen a reduction in purely basic science studies that do not translate into clinical practices, as the emphasis shifts towards applied research with immediate clinical relevance. - Single-Center Studies:
There is a waning interest in single-center studies that do not contribute to broader, multi-institutional or population-based understanding of cardiovascular health, reflecting a trend towards larger cohort studies and multi-center trials. - Generalized Guidelines without Contextual Adaptation:
Research articles that merely reiterate existing clinical guidelines without contextual adaptation to specific populations or settings are becoming less common, as there is a push for more personalized medicine approaches.
Similar Journals
JAMA Cardiology
Transforming Insights into Cardiovascular Care.JAMA Cardiology, published by the American Medical Association, is a leading peer-reviewed journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor signifying its influence and relevance within the medical community. Established in 2016, this journal has quickly gained recognition, currently positioned in the Q1 quartile and ranked #2 out of 387 in its field according to Scopus, reflecting its commitment to high-quality research dissemination. As an esteemed publication, JAMA Cardiology aims to advance the understanding of cardiovascular health through rigorous studies, reviews, and clinical insights. The journal is dedicated to serving a diverse audience of researchers, clinicians, and students, ensuring they have access to groundbreaking findings and comprehensive discussions that shape contemporary cardiology. Although it is not an open-access journal, articles published within it play a pivotal role in informing clinical practice and guiding future research in cardiovascular health, making it an essential resource for anyone engaged in this vital field.
Journal fur Kardiologie
Unveiling the Latest in Cardiac Health Research.The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.
Archives of Cardiovascular Diseases
Elevating knowledge in cardiovascular diseases for better outcomes.The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.
PROGRESS IN CARDIOVASCULAR DISEASES
Advancing the Frontiers of Cardiovascular MedicinePROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.
AMERICAN HEART JOURNAL
Empowering Cardiologists with Groundbreaking InsightsAMERICAN HEART JOURNAL, published by MOSBY-ELSEVIER, stands at the forefront of cardiovascular research, encompassing a vast array of studies focused on heart health, cardiology, and related medical therapies. Established in 1925 and set to continue its legacy into 2024, this esteemed journal holds a prestigious Q1 ranking in the category of Cardiology and Cardiovascular Medicine, reflecting its commitment to quality and significant influence in the field, as evidenced by its 85th percentile ranking in Scopus. With a dedicated readership of researchers, clinicians, and students, the journal serves as a critical platform for sharing groundbreaking findings, innovative techniques, and comprehensive reviews that strive to advance cardiovascular science. Although it does not currently offer open access, the AMERICAN HEART JOURNAL remains an indispensable resource for anyone invested in the evolution and improvement of heart health.
ACTA CARDIOLOGICA
Transforming challenges into solutions in cardiology.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
CURRENT PROBLEMS IN CARDIOLOGY
Driving Progress in Heart Health ResearchCURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.
HEART & LUNG
Pioneering Insights for Better Patient OutcomesHEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.
AMERICAN JOURNAL OF CARDIOLOGY
Exploring Breakthroughs in Cardiovascular Science Since 1958The American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.
Journal of Cardiovascular Development and Disease
Leading the charge in cardiovascular research and discovery.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.